Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PARINEX vs APP Heparin in Chronic Renal Failure
NCT00914472Phase 3Unknown
- Sponsor
- Azidus Laboratories Limited
- Start
- Apr 2010
- Primary completion
- Mar 2011
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of heparin in thrombosis (2 arms), sponsored by Azidus Laboratories Limited. Primary endpoint: Effectiveness of heparin in thrombi formation. Status: unknown.
02
Drugs
heparin
03
Conditions
thrombosis
Beyond the preview
Go deeper on NCT00914472.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00914472.